Wellstone Receives FTC Testing Facility Results
March 23 2005 - 10:43AM
PR Newswire (US)
Wellstone Receives FTC Testing Facility Results DURHAM, N.C., March
23 /PRNewswire-FirstCall/ -- Wellstone Filters (OTC:WLSF) (BULLETIN
BOARD: WLSF) announced that it has received results from an
independent FTC testing facility that confirm the Company's
expectations for their patented filter technology. Test results
showed significant reductions in tar and nicotine and similar
reductions of other classes of known carcinogens. "We are delighted
with the results and will go into production immediately," stated
CEO L.J. Hand. Wellstone believes that its patented filter
formulation removes tars and certain carcinogens, without
compromising taste. However, any claim as to the benefit of any
Wellstone cigarette to be sold will be made within the parameters
prescribed by the Federal Trade Commission. Wellstone emphasizes
that NO cigarette is safe. This corporate communication by
Wellstone is not intended to induce any person to purchase future
Wellstone tobacco products. ABOUT THE COMPANY Wellstone Filters,
Inc. has developed and patented filter material that removes
certain carcinogens and other toxins produced when tobacco is
smoked -- without removing the compounds thought to be associated
with the pleasurable effects of smoking. Wellstone seeks to promote
material for cigarette filters that will enable cigarette
manufacturers to provide consumers with an equally enjoyable
cigarette with substantially fewer carcinogens. For more
information, please see http://www.wellstonefilters.com/ or call
Investor relations at 303-620-9194. In addition, all current
shareholders, and interested parties should sign into our private
Corporate Guest Book, http://www.corporateguestbook.com/?WLSF to
receive timely updates and information on any future developments
as they happen. Note: Except for the historical information
contained herein, this new release contains forward-looking
statements that involve substantial risks and uncertainties. Among
the factors that could cause actual results or timelines to differ
materially are risks associated with research and clinical
development, regulatory approvals, supply capabilities and reliance
on third- party manufacturers, product commercialization,
competition, litigation, and the other risk factors listed from
time to time in reports filed by Wellstone with the Securities and
Exchange Commission, including but not limited to risks described
under the caption "Important Factors That May Affect Our Business,
Our Results of Operation and Our Stock Price." The forward-looking
statements contained in this news release represent judgments of
the management of Wellstone as of the date of this release.
Wellstone and its managers and agents undertake no obligation to
publicly update any forward-looking statements. DATASOURCE:
Wellstone Filters CONTACT: Wellstone Filters, Inc.,
http://www.wellstonefilters.com/, Investor Relations,
+1-303-620-9194 Web site: http://www.wellstonefilters.com/
http://www.corporateguestbook.com/?WLSF
Copyright